APOE and Alzheimer disease: Notably, a recent Bordeaux-3C prospective cohort study [35] assessed the 10-year risk of AD in 1037 participants and found that the APOE4 carriers with frequent reactivations of HSV-1 had a three-fold increased risk of AD, suggesting the interaction between APOE gene and HSV-1 in AD.